Empowering Life Sciences with Advanced AI Solutions.
Edge monitors FDA approvals, trials, and press releases—delivering instant insights for drug, regulatory, and market strategy.
Edge transforms conferences, advisory boards, and updates into actionable intelligence with 95%+ accuracy.
Insights are contextualized with 400K+ trials, 35M+ citations, and global precedents for unmatched intelligence.
Add voice memos or notes to personalize captured content
Highlight key clinical data, safety signals, and competitive insights
Create custom snapshots for regulatory submissions and follow-ups
Instantly share intelligence with global pharma teams—Clinical, Medical, Regulatory, and Commercial—with role-based access and 21 CFR Part 11 compliance.
Edge integrates with pharma systems—syncing insights, notes, and analyses via Veeva Vault, SharePoint, and more.
It delivers:
Traceability — Capture to decision, fully compliant
Centralized Access — Unified data for all teams
Continuity — Connecting conferences to commercialization
By linking live observations with structured intelligence, Edge speeds learning and strengthens decisions.
Whether analyzing oncology therapy landscapes at ASCO, tracking neuroscience disease progression at AAN, assessing predictive biomarkers at AACR, or evaluating real-world patient outcomes at ISPOR,
Edge delivers the depth and accuracy needed to drive pharmaceutical innovation forward with instant, traceable intelligence.
We've covered most of the common questions below.
Pienomial is an AI LifeScience company that transforms how professionals access and analyze data in support of their business goals. Whether you are in Big Pharma or a small biotech; or a service provider to the industry Pienomial can help you in a range of functions in your business.
Our flagship platform, Knolens, uses advanced AI to provide real-time, accurate insights from clinical trials, scientific publications, and more. Pienomial helps streamline product development and improve decision-making, empowering Life Sciences organizations to stay ahead in the industry.
Knolens uses a combination of multiple techniques including automated AI pipelines, human verification and domain expertise to ensure high relevance, accuracy and reliability of the data used in the analysis.
Knolens can easily integrate and analyze a wide range of structured and unstructured information including but not limited to FDA & EMA databases, PubMed and scientific journals, financial reports etc. Our customers can also, optionally, choose to leverage the power of our platform with their internal knowledge bases and data sources.
Yes. The Knolens platform is built for modularity and configurability. Our customers choose to use it in a way that provides them unique benefits specific to their business goals while leveraging the power of a stable, proven platform.
Book a free demo to see how KnolScapes streamlines scenario modeling for clinical, market access, competitive, and regulatory strategy—helping pharma teams optimize decisions.